4D Molecular Therapeutics, Inc. logo

4D Molecular Therapeutics, Inc. (FDMT)

Market Closed
16 Oct, 08:00 PM
NASDAQ (NGS) NASDAQ (NGS)
$
12. 14
-0.73
-5.6721%
$
696.84M Market Cap
- P/E Ratio
- Div Yield
794,500 Volume
-3.06 Eps
$ 12.87
Previous Close
Add Transaction
Day Range
12 12.84
Year Range
6.96 16.93
Want to track FDMT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

4D Molecular Therapeutics, Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
Audrey Woon
Audrey Woon Evergreen Quality Fund GP, Ltd.
951,474 $7.14M $11.56M $4.42M 62%
NCG
Noah C Goldberg Jain Global LLC
23,537 $271,146.24 $302,921.19 $31,774.95 11.72%
Jay Kasting
Jay Kasting Landing Point Financial Group, LLC
18,500 $138,750 $238,280 $99,530 71.73%
Zachary Canonico
Zachary Canonico DIADEMA PARTNERS LP
571,107 $6.58M $7.21M $633,928.77 9.64%
Bryan Buchert
Bryan Buchert Kera Capital Partners Inc.
24,068 $89,292 $298,914.93 $209,622.93 234.76%
Mark Schafer
Mark Schafer Police & Firemen's Retirement System of New Jersey
13,831 $108,857.98 $168,738.2 $59,880.22 55.01%
Yuen Man Lee
Yuen Man Lee Persistent Asset Partners Ltd.
145,585 $1.68M $1.79M $113,556.3 6.77%
CMP
Craig M. Pesce Marshall & Sterling Wealth Advisors Inc.
100 $869 $1,234.5 $365.5 42.06%
GFM
GF Fund Management Co. Ltd. GF Fund Management Co. Ltd.
1,082 $6,412.62 $13,384.34 $6,971.72 108.72%